Skip to:


Feb 13 | Mabtech is relocating to new facilities

To better serve our customers, Mabtech Head Office in Stockholm will be relocating into new and larger facilities on March 1, 2017. The new facilities will ease further expansion of our business in response to a growing demand for ELISpot and FluoroSpot kits and monoclonal antibodies.

More information about important dates and the relocation more

Feb 13 | Two new triple-color FluoroSpot-kits

We have added two FluoroSpot-kits to our portfolio:

• IFN-γ/IL-10/IL-5
• IFN-γ/IL-17A/IL-5

These kits will facilitate the study of T-cell populations with different secretion profiles. Both kits are supplied with pre-coated plates for a convenient and rapid assay with minimized variability. more

Jan 26 | IFN-γ mAb for Neutralization and Western blot launched

Our new anti-human IFN-γ mAb MT111W is recommended for neutralization of human IFN-γ bioactivity and Western blot analysis. The antibody cross-reacts with IFN-γ from Old world non-human primates.

mAb MT111W is available in the web shop. more